Pancreatic Cancer Research

ResearcherSamsung Medical CenterNo recent work listed

Tae Yeon Jeon

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-7796-1307; OpenAlex author ID A5080535941. Sources: OpenAlex.

Their work

Papers
3 (first author 2, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
8
Papers, trials and grants by year

2022: 2 papers · 2023: 1 paper

Papers 3

  1. Differentiation of autoimmune pancreatitis from pancreatic adenocarcinoma using CT characteristics: a systematic review and meta-analysis. First author DOI 10.1007/s00330-023-09959-5↗
  2. Systematic review and meta-analysis of MRI features for differentiating autoimmune pancreatitis from pancreatic adenocarcinoma. First author DOI 10.1007/s00330-022-08816-1↗
  3. ADC values from diffusion-weighted imaging may be lower for autoimmune pancreatitis than for pancreatic ductal adenocarcinoma. Last author DOI 10.1016/j.dld.2022.04.003↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Sung‐Hoon Moon · 3 shared papers, 2022–2023 · strength 0.66
  2. Seung Bae Yoon · 3 shared papers, 2022–2023 · strength 0.66
  3. Sang Min Lee · 2 shared papers, 2022–2023 · strength 0.40
  4. Myung‐Hwan Kim · 1 shared paper, 2022 · strength 0.20
  5. Moon Hyung Choi · 1 shared paper, 2023 · strength 0.19
  6. Dong Woo Shin · 1 shared paper, 2023 · strength 0.19
  7. Min-Jeong Kim · 1 shared paper, 2023 · strength 0.19
  8. Ji Hye Min · 1 shared paper, 2023 · strength 0.19

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.